Weight Loss Tablets in the UK: How They Work, Benefits & Who They’re For
Weight Loss Tablets in the UK: How They Work, Benefits & Who They’re For
Weight loss injections get most of the headlines. Mounjaro, Wegovy, Ozempic. If you’ve been anywhere near a health news site in the past two years, you’ve seen those names. But injections aren’t the only option, and for a lot of people, they’re not the right one either.
Weight loss tablets have been prescribed in the UK for decades. They’re effective, they’re well-understood, and for the right patient, they can deliver results that rival the newer injectable medications. The problem? Most of the information online either ignores them entirely or lumps them in with dubious “slimming pills” sold through unregulated websites.
Here’s what you actually need to know.
There are three main prescription weight loss tablets available through UK clinics. Each works differently, suits different patients, and comes with its own set of considerations.
Phentermine is one of the longest-established appetite suppressants in clinical use. It works on the central nervous system by increasing norepinephrine levels, which suppresses hunger signals and can give you a mild energy boost. Most patients describe the effect as simply not thinking about food as much, rather than any dramatic physical sensation.
Phentermine is prescribed as a daily oral tablet, typically for an initial 12-week course. It’s classed as an unlicensed medicine in the UK, which means it can only be prescribed by specialist private clinics operating under strict MHRA agreements. Your GP cannot prescribe it.
Diethylpropion (sometimes referred to by its brand name Tenuate) works through a similar mechanism to phentermine, targeting the appetite control centre in the brain to reduce hunger and cravings. Some patients find it slightly milder in its effects, which can make it a better fit for those who are sensitive to stimulant-based medications.
Like phentermine, diethylpropion is prescribed on a named-patient basis through specialist weight loss clinics and requires ongoing medical monitoring.
Orlistat takes a completely different approach. Rather than suppressing appetite, it blocks your body from absorbing roughly a third of the fat in the food you eat. It’s the only weight loss tablet available through the NHS and can also be bought over the counter at a lower dose (branded as Alli).
Orlistat suits patients who prefer a non-stimulant option, though it does require a low-fat diet to avoid unpleasant digestive side effects.
The two main mechanisms are appetite suppression and fat absorption reduction.
Phentermine and diethylpropion both act on the brain’s appetite control centre. They increase levels of certain neurotransmitters (primarily norepinephrine) that tell your body you’re not hungry. The result is fewer cravings, smaller portions, and less of the mental battle that makes dieting feel impossible for so many people. You still eat. You just don’t want to eat as much.
Orlistat works in the gut, not the brain. It inhibits pancreatic lipase, the enzyme responsible for breaking down dietary fat. Undigested fat passes through the body rather than being stored. The weight loss is more gradual, but it doesn’t carry the same stimulant-related considerations.
Both approaches are most effective when combined with dietary changes and increased physical activity. No tablet replaces the fundamentals. What it does is make the fundamentals dramatically easier to follow.
Weight loss tablets aren’t for everyone, and a responsible clinic will tell you that upfront.
Generally, prescription appetite suppressants like phentermine and diethylpropion are considered when a patient has a BMI of 30 or above, or a BMI of 27 or above with weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol. Beyond BMI, clinicians also assess cardiovascular health, existing medications, and mental health history before prescribing.
Tablets can be particularly well-suited for patients who dislike needles or find the idea of weekly injections off-putting, those looking for a more affordable option (tablet treatments typically cost less per month than GLP-1 injectables), people who haven’t responded well to diet and exercise alone but don’t meet the criteria for injectable treatments, and patients who need short-term support to break through a weight loss plateau.
The key distinction is that tablets tend to work best as part of a structured, time-limited programme rather than as a long-term medication.
This is the question most people want answered, and the honest answer is: it depends on you.
GLP-1 injections like Mounjaro and Wegovy have shown impressive clinical trial results, with patients losing up to 22.5% of their starting body weight over 72-88 weeks. Orlistat, by comparison, helps roughly one in five patients lose 10% of body weight over a year. Phentermine and diethylpropion sit somewhere in between, with most patients seeing meaningful results within the initial 12-week course.
But effectiveness isn’t just about the clinical trial numbers. Adherence matters. A medication you actually take consistently will always outperform one you abandon after a few weeks. For patients who struggle with injections, who experience intolerable GI side effects from GLP-1 medications, or who prefer a tablet-based approach, prescription weight loss pills may deliver better real-world results than a technically “stronger” medication they can’t stick with.
Cost is also a factor. Tablet-based treatments from specialist clinics typically start from around £105 for a four-week supply, compared to £149-£339 per month for injectable treatments. Over a 12-week course, that difference adds up.
This is where things get important. Prescription weight loss tablets UK are regulated medications, and the quality of the prescribing process matters as much as the medication itself. A reputable clinic will conduct a full medical assessment before prescribing anything.
A reputable clinic will conduct a full medical assessment before prescribing anything. That means reviewing your BMI and weight history, checking cardiovascular risk factors, evaluating your current medications, and considering your mental health profile. If tablets aren’t clinically appropriate, they should tell you so and guide you toward alternatives.
Ongoing monitoring is equally important. Phentermine and diethylpropion require regular blood pressure and heart rate checks, with your GP kept informed of treatment throughout. Any clinic that posts a prescription after a five-minute online form should raise red flags.
Clinics like Weight Medics, which has operated as a CQC-registered medical weight loss clinic for over 29 years, offer doctor-led assessments with strict eligibility criteria, regular monitoring, and a clear clinical framework around every prescription. That kind of structure is what separates safe, effective treatment from a gamble.
Weight loss tablets aren’t a magic fix and no responsible clinician will present them as one. But for the right patient, prescribed correctly and monitored properly, they remain one of the most effective tools available for breaking through the cycle of failed diets and regained weight.
The surge in popularity of injectable medications has pushed tablets out of the conversation, but that doesn’t mean they’ve stopped working. For many people in the UK, a prescription appetite suppressant is the most practical, affordable, and effective route to sustainable weight loss.
The most important step isn’t choosing between tablets and injections. It’s choosing a clinic that will assess you properly, prescribe responsibly, and support you through the entire process.
Orlistat is the only weight loss tablet currently available through the NHS. Phentermine and diethylpropion are prescribed exclusively by specialist private clinics. GLP-1 injections (Wegovy, Mounjaro) are available through NHS specialist weight management services, but with strict eligibility criteria and significant waiting times.
Most patients notice reduced appetite within the first few days of taking phentermine or diethylpropion. Visible weight loss typically begins within the first two to four weeks. An initial 12-week course is standard before results are formally assessed and a decision is made about continuing treatment.
Potentially, but this is exactly why a full medical assessment is required before prescribing. Phentermine and diethylpropion can interact with certain medications, particularly antidepressants, blood pressure medications, and other stimulants. A qualified clinician will review your full medication profile before prescribing.
When prescribed following a thorough medical assessment and monitored by qualified clinicians, prescription weight loss tablets have a well-established safety profile. Risks increase when they’re obtained without proper screening. Common side effects of appetite suppressants include dry mouth, difficulty sleeping, and mild restlessness, which typically ease as your body adjusts.